CD8A and renal cell carcinoma: In the context of immunotherapy response prediction, Kinget et al. [328] conducted a comprehensive multiomics mapping of advanced RCC, identifying patient-specific crosstalk between pro-inflammatory tumor-associated macrophages and exhausted CD8 + T cells.